WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 12'4701 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 13'4751 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 29'955  29'501  29'043  28'583  28'120  24'408  19'741  15'096 
Births 601  601  601  600  599  576  565  499 
Surviving infants 592  592  591  590  589  565  551  481 
Pop. less than 5 years 2'951  2'944  2'934  2'925  2'914  2'782  2'726  2'295 
Pop. less than 15 years 8'641  8'602  8'560  8'523  8'484  8'232  7'505  6'140 
Female 15-49 years 7'917  7'815  7'706  7'593  7'472  6'377  4'948  3'634 

Number of reported case

(Click for retrospective incidence data for Venezuela (Bolivarian Republic of))
Diphtheria 31 
Japanese encephalitis
Measles 22  9'881  9'750 
Mumps 2'740  3'353  7'509  1'007  5'851 
Pertussis 555  1'389  3'247 
Polio* 11 
Rubella 13'927 
Rubella (CRS)
Tetanus (neonatal) 28  129 
Tetanus (total) 14  26  13  17  27  99  476 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Venezuela (Bolivarian Republic of))
Vaccine year result method % card seen                                                
BCG 1999  90  MICS     96  95  92  91  90  99  82  72 
DTP1 1999  88  MICS     90  90  90  86  87  92 
DTP3 1999  59  MICS     81  78  78  84  50  77  63  56 
HepB_BD          67  78  73  66  73  14 
HepB3          81  78  78  84  53 
Hib3          81  78  78  84  51 
JapEnc         
MCV 1999  57  MICS     87  86  79  87  93  84  62  50 
MCV2          33  26  31 
PCV1         
PCV3         
Pol3 1999  40  MICS     73  78  74  75  76  86  72  95 
Rota1          83  76  65  55  50 
Rota_last          76  66  49  54  50 
Rubella1          87  86  79  87  82 
TT2plus          51  37  32  26  39 
PAB         
VAD1         
YFV          87  73  48  77  77  17 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Venezuela (Bolivarian Republic of))
BCG 96  95  92  91  90  99  82  72 
DTP1 90  90  90  86  87  92  84  79 
DTP3 81  78  78  84  50  77  63  56 
HepB3 81  78  78  84  53 
Hib3 81  78  78  84  51 
MCV 87  86  79  87  93  84  61  50 
PAB 50  50  50  50  52 
PCV3
Pol3 73  78  74  75  76  86  72  95 
Rota_last 76  66  49  54  50 
YFV 87  73  48  77  77  17 

Number of districts in the country 335  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 34
From 80 to 89% 22
From 50 to 79% 40
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 5 years; Yes
DTwPHibHep 2, 4, 6, 18 months; Yes
HepB birth; Yes
Influenza 6, 7 months; Yes and risk groups
MMR 12 months; 5 years; Yes
MenBC 1, 2 days; risk groups
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_ps > 60 years; + 5 years; Yes
Rotavirus 2, 4 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes
YF 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  No  No  No  NA  No  Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   250      367 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 335  367  367  367  367  367  367 
Nº districts with DTP3 coverage >=80% number 188  189  165  173    75  43 
% of districts with DTP3 coverage >=80% From 0 to 100% 56  51  45  47    20  12 
Nº districts with measles (MCV1) coverage >=95% number 103  113  76  91       
% of districts with MCV1 coverage >=95% From 0 to 100% 31  31  21  25       

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100    100   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.